Tobam Laboratory Corp Of America Holdings Transaction History

Tobam

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$209.01 - $232.56 $66,883 - $74,419	-320 Reduced 35.13%	591 $129,000
Q4 2023 Jan 26, 2024	BUY	$197.69 - $227.29 $111,497 - $128,191	564 Added 162.54%	911 $207,000
Q3 2023 Oct 31, 2023	SELL	$201.05 - $221.7 $55,690 - $61,410	-277 Reduced 44.39%	347 $70,000
Q2 2023 Jul 31, 2023	BUY	$211.93 - $241.33 $31,153 - $35,475	147 Added 30.82%	624 $151,000
Q1 2023 May 03, 2023	SELL	$213.32 - $257.83 $9,386 - $11,344	-44 Reduced 8.45%	477 $109,000
Q3 2022 Nov 02, 2022	SELL	$204.81 - $262.19 $85,405 - $109,333	-417 Reduced 44.46%	521 $107,000
Q2 2022 Aug 02, 2022	BUY	$213.86 - $277.87 $89,179 - $115,871	417 Added 80.04%	938 $220,000
Q1 2022 Apr 25, 2022	BUY	$259.82 - $298.18 $50,405 - $57,846	194 Added 59.33%	521 $137,000
Q2 2021 Aug 11, 2021	BUY	$251.87 - $278.14 $82,361 - $90,951	327 New	327 $90,000

128

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.